Wilkins Investment Counsel Inc. is a registered investment advisor with a long history of managing assets for high-net-worth individuals and institutions. The firm has a strong track record of success in the investment management industry, with a focus on value investing. They are known for their disciplined approach to investing, emphasizing fundamental analysis and long-term growth potential.
This sale comes amidst a period of significant growth for Colgate-Palmolive, with the company reporting record-breaking revenue and earnings in the recent quarter. The company’s strong performance has been driven by several factors, including:
Colgate-Palmolive is a multinational consumer goods company that manufactures and markets a wide range of personal care products, including toothpaste, mouthwash, soap, and other hygiene products. The company has a strong global presence, with operations in over 190 countries. Colgate-Palmolive is a market leader in its industry, holding a significant market share in many of its product categories.
Colgate-Palmolive Announces Dividend The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 1.89%. Colgate-Palmolive’s dividend payout ratio (DPR) is 63.29%. Wall Street Analyst Weigh In A number of brokerages have weighed in on CL. BNP Paribas began coverage on Colgate-Palmolive in a research report on Monday, June 24th. They issued an “outperform” rating and a $109.00 price target for the company. TD Cowen upped their target price on Colgate-Palmolive from $110.00 to $115.00 and gave the stock a “buy” rating in a research report on Tuesday, July 30th. Barclays increased their price target on Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a report on Monday, July 29th. Morgan Stanley boosted their price objective on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research note on Monday, July 29th. Finally, Bank of America increased their price objective on Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. Nine research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $102.63.
The company’s portfolio includes a wide range of products, including toothpaste, mouthwash, toothbrushes, and other oral care products. Colgate-Palmolive is a global leader in the oral care industry, with a strong brand presence and a vast distribution network. The company’s success is driven by its focus on innovation, research and development, and a commitment to sustainability.
Receive News & Ratings for Colgate-Palmolive Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Colgate-Palmolive and related companies with MarketBeat.com’s FREE daily email newsletter.
news is a contributor at WhySkin. We are committed to providing well-researched, accurate, and valuable content to our readers.
